5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
Evidence-based guide to lisinopril dosing in Hispanic and Latino patients, covering ALLHAT subgroup data, pharmacogenomic considerations, diabetes-related renoprotection, and practical titration strategies.
A guide covering lisinopril pharmacogenomics, ethnicity-stratified trial data, and practical East Asian dosing recommendations for ACE inhibitor therapy.
A comprehensive, evidence-based review of how lisinopril's safety profile differs in East Asian patients, covering ACE inhibitor-induced cough rates, angioedema risk, pharmacogenomics, dosing considerations, and ethnicity-stratified trial data.
A clinical review of how lisinopril's safety and efficacy profile is discussed differently for Black and African ancestry patients, covering angioedema risk, blood-pressure response, ACE inhibitor pharmacogenomics, and guideline-based alternatives, with an explicit map of what is directly studied versus extrapolated.
Evidence-based review of lisinopril efficacy differences in South Asian populations, including pharmacogenomic data, ACE gene polymorphisms, RAAS activity patterns, and adjusted dosing strategies.